Go Pro

Best Stocks Under $10 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $10.00 (10 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Curaleaf stock logo

1. Curaleaf OTCMKTS:CURLF

$9.99 0.00 (0.00%)
As of 08/21/2026 03:59 PM Eastern

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. More about Curaleaf

Market Capitalization
$2.33 billion
Consensus Rating
Strong Buy
Volume
225,283 shares
Average Volume
156,275 shares
Today's Range
$9.57
$10.00
50-Day Range
$3.64
$10.06
Ur Energy stock logo

2. Ur Energy NYSEAMERICAN:URG

$1.42 0.00 (0.00%)
As of 08/21/2026 04:10 PM Eastern

Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur Energy

Market Capitalization
$564.29 million
Consensus Rating
Buy
Consensus Price Target
$2.32 (+63.1% Upside)
Volume
10.56 million shares
Average Volume
6.13 million shares
Today's Range
$1.35
$1.43
Centrica stock logo

3. Centrica OTCMKTS:CPYYY

$8.50 0.00 (0.00%)
As of 08/21/2026 03:58 PM Eastern

Centrica plc operates as an integrated energy company in the United Kingdom, Ireland, Scandinavia, North America, and internationally. More about Centrica

Market Capitalization
$9.82 billion
Consensus Rating
Buy
Volume
92,218 shares
Average Volume
89,249 shares
Today's Range
$8.44
$8.60
50-Day Range
$8.19
$9.93
CuriosityStream stock logo

4. CuriosityStream NASDAQ:CURI

$2.76 0.00 (0.00%)
As of 08/21/2026 04:00 PM Eastern

CuriosityStream Inc operates as a factual content streaming service and media company. The company provides premium video and audio programming services in various categories of factual entertainment, including science, history, society, nature, lifestyle, and technology through direct subscription video on-demand (SVoD) platforms accessible by internet connected devices, or indirectly via distribution partners who deliver CuriosityStream content via distributor's platform or system, as well as through bundled content licenses for SVoD and linear offerings, talks and courses, and partner bulk sales. More about CuriosityStream

Market Capitalization
$163.78 million
P/E Ratio
276.00
Consensus Rating
Buy
Consensus Price Target
$5.50 (+99.3% Upside)
Volume
809,293 shares
Average Volume
1.95 million shares
Aclaris Therapeutics stock logo

5. Aclaris Therapeutics NASDAQ:ACRS

$6.41 0.00 (0.00%)
As of 08/21/2026 04:00 PM Eastern

Aclaris Therapeutics, Inc a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. More about Aclaris Therapeutics

Market Capitalization
$896.25 million
Consensus Rating
Buy
Consensus Price Target
$11.50 (+79.4% Upside)
Volume
2.21 million shares
Average Volume
2.05 million shares
Today's Range
$6.29
$6.50
iBio stock logo

6. iBio NASDAQ:IBIO

$1.43 0.00 (0.00%)
As of 08/21/2026 04:00 PM Eastern

iBio, Inc, a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. More about iBio

Market Capitalization
$71.04 million
Consensus Rating
Buy
Consensus Price Target
$5.00 (+249.7% Upside)
Volume
754,676 shares
Average Volume
778,745 shares
Today's Range
$1.42
$1.50
Larimar Therapeutics stock logo

7. Larimar Therapeutics NASDAQ:LRMR

$4.18 0.00 (0.00%)
As of 08/21/2026 04:00 PM Eastern

Larimar Therapeutics, Inc, a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. More about Larimar Therapeutics

Market Capitalization
$434.22 million
Consensus Rating
Buy
Consensus Price Target
$11.67 (+179.1% Upside)
Volume
699,419 shares
Average Volume
1.22 million shares
Today's Range
$4.09
$4.21
Inventiva stock logo

8. Inventiva NASDAQ:IVA

$4.68 0.00 (0.00%)
As of 08/21/2026 04:00 PM Eastern

Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. More about Inventiva

Market Capitalization
$972.08 million
Consensus Rating
Buy
Consensus Price Target
$16.56 (+253.8% Upside)
Volume
461,396 shares
Average Volume
688,336 shares
Today's Range
$4.63
$4.78
Uranium Royalty stock logo

9. Uranium Royalty NASDAQ:UROY

$4.38 0.00 (0.00%)
As of 08/21/2026 04:00 PM Eastern

Uranium Royalty Corp. operates as a pure-play uranium royalty company. It acquires, accumulates, and manages a portfolio of geographically diversified uranium interests. More about Uranium Royalty

Market Capitalization
$1.67 billion
P/E Ratio
219.11
Consensus Rating
Buy
Consensus Price Target
$4.13 (-5.8% Downside)
Volume
2.81 million shares
Average Volume
3.24 million shares
Aquestive Therapeutics stock logo

10. Aquestive Therapeutics NASDAQ:AQST

$4.66 0.00 (0.00%)
As of 08/21/2026 04:00 PM Eastern

Aquestive Therapeutics, Inc operates as a pharmaceutical company in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. More about Aquestive Therapeutics

Market Capitalization
$584.89 million
Consensus Rating
Buy
Consensus Price Target
$8.50 (+82.4% Upside)
Volume
2.02 million shares
Average Volume
3.66 million shares
Today's Range
$4.52
$4.72
Inhibikase Therapeutics stock logo

11. Inhibikase Therapeutics NASDAQ:IKT

$2.39 0.00 (0.00%)
As of 08/21/2026 04:00 PM Eastern

Inhibikase Therapeutics, Inc, a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. More about Inhibikase Therapeutics

Market Capitalization
$333.50 million
Consensus Rating
Buy
Consensus Price Target
$5.40 (+125.9% Upside)
Volume
309,313 shares
Average Volume
518,910 shares
Today's Range
$2.37
$2.42
Red Cat stock logo

12. Red Cat NASDAQ:RCAT

$9.62 0.00 (0.00%)
As of 08/21/2026 04:00 PM Eastern

Red Cat Holdings, Inc engages in the provision of various products, services, and solutions to the drone industry. The company operates through two segments: Enterprise and Consumer. More about Red Cat

Market Capitalization
$1.18 billion
Consensus Rating
Buy
Consensus Price Target
$20.40 (+112.1% Upside)
Volume
8.53 million shares
Average Volume
9.68 million shares
Today's Range
$9.55
$10.04
Inuvo stock logo

13. Inuvo NYSEAMERICAN:INUV

$0.73 0.00 (0.00%)
As of 08/21/2026 04:10 PM Eastern

Inuvo, Inc engages in the advertising technology and services business primarily in the United States. It sells information technology solutions to brands, agencies, and large consolidators of advertising demand (platforms). More about Inuvo

Market Capitalization
$11.96 million
Consensus Rating
Buy
Consensus Price Target
$5.00 (+589.0% Upside)
Volume
189,697 shares
Average Volume
305,910 shares
Today's Range
$0.71
$0.76
Lexeo Therapeutics stock logo

14. Lexeo Therapeutics NASDAQ:LXEO

$4.88 0.00 (0.00%)
As of 08/21/2026 04:00 PM Eastern

Lexeo Therapeutics, Inc operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. More about Lexeo Therapeutics

Market Capitalization
$400.38 million
Consensus Rating
Buy
Consensus Price Target
$18.75 (+284.2% Upside)
Volume
509,587 shares
Average Volume
919,866 shares
Today's Range
$4.84
$5.20
Global Net Lease stock logo

15. Global Net Lease NYSE:GNL

$9.04 0.00 (0.00%)
As of 08/21/2026 03:58 PM Eastern

Global Net Lease, Inc (NYSE: GNL) is a publicly traded real estate investment trust listed on the NYSE. The firm focused on acquiring a diversified global portfolio of commercial properties, with an emphasis on sale-leaseback transactions involving single tenant, mission critical income producing net-leased assets across the United States, Western and Northern Europe.

Market Capitalization
$1.91 billion
Consensus Rating
Buy
Consensus Price Target
$10.25 (+13.4% Upside)
Volume
1.46 million shares
Average Volume
2.80 million shares
Today's Range
$9.02
$9.14
Stereotaxis stock logo

16. Stereotaxis NYSEAMERICAN:STXS

$1.42 0.00 (0.00%)
As of 08/21/2026 04:10 PM Eastern

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. More about Stereotaxis

Market Capitalization
$142.28 million
Consensus Rating
Buy
Consensus Price Target
$3.70 (+160.6% Upside)
Volume
357,867 shares
Average Volume
757,025 shares
Today's Range
$1.40
$1.47
Novagold Resources stock logo

17. Novagold Resources NYSEAMERICAN:NG

$8.72 0.00 (0.00%)
As of 08/21/2026 04:10 PM Eastern

NovaGold Resources Inc explores for and develops gold mineral properties in the United States. Its principal asset is the Donlin Gold project consisting of 493 mining claims covering an area of approximately 29,008 hectares located in the Kuskokwim region of southwestern Alaska. More about Novagold Resources

Market Capitalization
$3.83 billion
Consensus Rating
Buy
Consensus Price Target
$12.42 (+42.4% Upside)
Volume
4.69 million shares
Average Volume
4.76 million shares
Today's Range
$8.65
$9.07
Nomura stock logo

18. Nomura NYSE:NMR

$9.72 0.00 (0.00%)
As of 08/21/2026 03:58 PM Eastern

Nomura Holdings, Inc provides various financial services to individuals, corporations, financial institutions, governments, and governmental agencies worldwide. More about Nomura

Market Capitalization
$28.52 billion
P/E Ratio
11.30
Consensus Rating
Buy
Consensus Price Target
$10.20 (+4.9% Upside)
Volume
536,711 shares
Average Volume
803,276 shares
Orla Mining stock logo

19. Orla Mining NYSEAMERICAN:ORLA

$9.44 0.00 (0.00%)
As of 07/31/2026

Orla Mining Ltd. acquires, explores, develops, and exploits mineral properties. The company explores for gold, silver, zinc, lead, and copper deposits. More about Orla Mining

Market Capitalization
$3.27 billion
P/E Ratio
13.88
Consensus Rating
Buy
Consensus Price Target
$27.00 (+186.0% Upside)
Average Volume
2.88 million shares
Today's Range
$9.44
$9.44
Achieve Life Sciences stock logo

20. Achieve Life Sciences NASDAQ:ACHV

$7.99 0.00 (0.00%)
As of 08/21/2026 04:00 PM Eastern

Achieve Life Sciences, Inc, a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. More about Achieve Life Sciences

Market Capitalization
$822.17 million
Consensus Rating
Buy
Consensus Price Target
$15.00 (+87.7% Upside)
Volume
1.06 million shares
Average Volume
1.35 million shares
Today's Range
$7.90
$8.19
Perspective Therapeutics stock logo

21. Perspective Therapeutics NYSEAMERICAN:CATX

$3.30 0.00 (0.00%)
As of 08/21/2026 04:10 PM Eastern

Perspective Therapeutics, Inc, together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. More about Perspective Therapeutics

Market Capitalization
$376.70 million
Consensus Rating
Buy
Consensus Price Target
$11.50 (+248.5% Upside)
Volume
1.14 million shares
Average Volume
1.15 million shares
Today's Range
$3.22
$3.44
Immuneering stock logo

22. Immuneering NASDAQ:IMRX

$5.30 0.00 (0.00%)
As of 08/21/2026 04:00 PM Eastern

Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. More about Immuneering

Market Capitalization
$342.91 million
Consensus Rating
Buy
Consensus Price Target
$17.50 (+230.2% Upside)
Volume
443,552 shares
Average Volume
655,642 shares
Today's Range
$5.28
$5.43
Niagen Bioscience stock logo

23. Niagen Bioscience NASDAQ:NAGE

$3.21 0.00 (0.00%)
As of 08/21/2026 04:00 PM Eastern

Niagen Bioscience, Inc is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. More about Niagen Bioscience

Market Capitalization
$255.64 million
P/E Ratio
17.83
Consensus Rating
Buy
Consensus Price Target
$10.33 (+221.9% Upside)
Volume
370,275 shares
Average Volume
693,483 shares
Palisade Bio stock logo

24. Palisade Bio NASDAQ:PALI

$2.10 0.00 (0.00%)
As of 08/21/2026 04:00 PM Eastern

Palisade Bio, Inc, a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. More about Palisade Bio

Market Capitalization
$365.97 million
Consensus Rating
Buy
Consensus Price Target
$9.00 (+328.6% Upside)
Volume
1.07 million shares
Average Volume
1.59 million shares
Today's Range
$2.08
$2.14
Entain stock logo

25. Entain OTCMKTS:GMVHF

$7.50 0.00 (0.00%)
As of 08/21/2026 03:48 PM Eastern

Entain Plc operates as a sports-betting and gaming company. The company provides online and multi-channel betting under the Ladbrokes name; street and online betting under the Coral name; online sports betting, casino, and gaming under the Eurobet name; scores, sports information, editorial and social content, and sports focused free-to play games under the 365Scores name; sports betting and games under the SuperSport and BetCity names; online betting under the bwin name; and sports betting, poker, and casino games under the Crystalbet name. More about Entain

P/E Ratio
16.07
Consensus Rating
Buy
Volume
2,874 shares
Average Volume
12,170 shares
Today's Range
$7.03
$7.53
50-Day Range
$7.00
$8.24